November BPC meeting highlights (Biocides, BPR)
BPC decided to approve New Biocidal Substances such as MIT and MIT (PT6) and DBNPA (PT11) in November 2024’s meeting.
November BPC meeting highlights. The Biocidal Product Committee (BPC) of the European Union has recently made several key decisions regarding the approval and renewal of active substances used in biocidal products according to BPR (Regulation EU 528/2012).
Renewed Substance:
- Epsilon-Metofluthrin: This substance, used in insecticides, acaricides, and products to control other arthropods, has been renewed for use in product-type 18.
Newly Approved Substances:
- 2,2-dibromo-2-cyanoacetamide (DBNPA): This substance will be used as a preservative in liquid-cooling and processing systems (product-type 11).
- 2-methyl-2H-isothiazol-3-one (MIT) and 2-methyl-2,3-dihydro-1,2-thiazol-3-one hydrochloride (MIT HCl): These substances will be used as preservatives for products during storage (product-type 6).
- Peracetic acid: Generated from 1,3-diacetyloxypropan-2-yl acetate and hydrogen peroxide, this substance will be used as a disinfectant and algaecide (product-type 2).
Rejected Substance:
- Epsilon-Metofluthrin: The BPC did not support the approval of this substance for use in repellents and attractants (product-type 19).
Implications of these decisions:
The decisions made by the BPC have significant implications for the biocidal products industry and for consumers. First, they ensure the availability of effective substances for pest control and disinfection, contributing to the protection of public health and environment. Furthermore, the rigorous evaluation and authorization process ensures that both substances and biocidal products incorporating them adhere to the highest standards of safety and environmental protection.
Next steps:
Companies wishing to use these substances in their products must submit the corresponding applications to the competent authorities of each Member State. These authorities will be responsible for assessing the applications and issuing the necessary authorizations for the marketing of biocidal products.
It can be expected that within approximately 6 months, the European Commission will publish the approval date for the active substances.
Therefore, before the approval date, it is recommended to:
- Analyze the strategy to be followed to authorize our biocides, both technically and economically
- Carry out efficacy tests and determine the physicochemical properties of the product (when applicable)
- Evaluate the risks of our products for the described uses
- Document the conclusions of the studies carried out and the characteristics of our products in IUCLID, the PAR, and the SPC.
- Discuss with the competent evaluating authorities any details that may pose a risk to the authorization application
- Submit the BPR application before the specified deadline
Do you need assistance to prepare and submit the BPR application for authorization of your biocidal products? Nordiik can help, contact us!
Source: ECHA
